Related Experiment Video
Updated: May 24, 2026
09:47
Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
Immunoproteasome-specific inhibitors and their application
Michael Basler1, Marcus Groettrup
1Department of Biology, Division of Immunology, University of Konstanz, Konstanz, Germany. michael.basler@uni-konstanz.de
Methods in Molecular Biology (Clifton, N.J.)
|February 22, 2012
Summary
This study details methods for characterizing immunoproteasome (IP) inhibitors, crucial for understanding immune responses. These methods assess inhibitor specificity, cell permeability, and functional impact on antigen presentation.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Immunoproteasomes (IPs) are crucial for immune functions, influencing T-cell responses and antigen presentation.
- Small molecule inhibitors are vital tools for studying IP roles in immunity.
Purpose of the Study:
- To describe methodologies for characterizing immunoproteasome-selective inhibitors.
- To provide a framework for analyzing the specificity and cell permeability of IP inhibitors.
- To enable functional investigation of IP inhibitors in the context of antigen presentation.
Main Methods:
- Assays for determining proteasome activity and subunit composition.
- Cell-based assays to evaluate inhibitor specificity and cell permeability.
- Analysis of peptide generation for MHC class I presentation.
Main Results:
- Established protocols for assessing immunoproteasome inhibitor selectivity.
- Demonstrated methods for evaluating the pharmacokinetic properties of IP inhibitors.
- Validated functional assays for IP inhibitors in immune surveillance.
Conclusions:
- Characterization methods are essential for developing selective immunoproteasome inhibitors.
- These methodologies facilitate the study of immunoproteasome function in immune processes.
- The described techniques support the advancement of immunomodulatory drug discovery.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...